Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2003-07-17
2008-09-30
Canella, Karen A. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S007800, C436S063000, C436S503000, C436S815000
Reexamination Certificate
active
07429448
ABSTRACT:
The present invention pertains to the use of a peptide molecule consisting in a maturation product of SMR1 (Submandibular rat protein 1) of structural formula QHNPR, as well as the biologically active derivatives of the said peptide, for preventing or treating diseases associated with a mineral ion imbalance in a human or an animal body. More particularly, the present invention relates to the therapeutic use of the above-cited molecules for preventing or treating an hydro-mineral imbalance in organs and tissues such as kidney, bone, dental enamel, dental ivory, gut matrix, pancreas or glandular gastric mucosa. This invention also deals with therapeutic compositions comprising a pharmaceutically active amount of the above-described therapeutic molecules as well as with therapeutic methods using the said therapeutic compositions. Finally, the present invention relates to processes for selecting ligand molecules that possess an agonist or an antagonist biological activity on the target receptor of the QHNPR pentapeptide as well as to the selected ligand molecules themselves.
REFERENCES:
patent: 5219548 (1993-06-01), Yang et al.
patent: 6589750 (2003-07-01), Rougeot et al.
patent: 0 240 975 (1987-10-01), None
patent: WO 90/03981 (1990-04-01), None
patent: WO 95/00848 (1995-01-01), None
Rougeot et al., “Selective processing of submandibular rat 1 protein at dibasic cleavage sites,” Eur. J. Biochem., vol. 219, 1994, pp. 765-773.
Purdie et al., “Effects of danazol on mineral homeostasis in normal postmenopausal women: preliminary communication,” Journal of Royal Society of Medicine, vol. 80, No. 11, 1987, pp. 681-682.
Rougeot et al., “Targets for SMR1-Pentapeptide Suggest a Link Between the Circulating Peptide and Mineral Transport,” Am. J. Physiology, vol. 273, No. 4 PT2, Oct. 1997, pp. R1309-1320.
Singer et al., “Recent evolution of genes encoding the prohormone-like protein SMR1 in the rat submandibular gland,” DNA Cell Biology, vol. 14, No. 2, 1995, pp. 137-144.
Courty et al., “Episodic evolution and rapid divergence of members of the rat multigene family encoding the salivary prohormone-like protein SMR1,” Molecular Biology and Evolution, vol. 12, No. 6, 1996, pp. 758-766.
Drews R et al., “Proteolytic Maturation of Protein C Upon Engineering the Mouse Mammary Gland to Express Furin,” Proceedings of the National Academy of Sciences of USA, vol. 92, No. 23, Nov. 1995, pp. 10462-10466.
Drucker et al., “Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase,” Nature Biotechnology, (Abstract), 1997.
U.S. Appl. No. 11/594,105, filed Nov. 08, 2006, Rougeot, et al.
U.S. Appl. No. 10/620,462, filed Jul. 17, 2003, Rougeot, et al.
Rougeon Francois
Rougeot Catherine
Canella Karen A.
Institut Pasteur
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Therapeutic use of the SMR1 protein and active derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of the SMR1 protein and active derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of the SMR1 protein and active derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3992941